SOW
TVTX icon

State of Wyoming’s Travere Therapeutics TVTX Stock Holding History

State of Wyoming’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-961
Closed -$36.7K – 2044
2025
Q4 		$36.7K Buy
+961
New +$31.2K ﹤0.01% 1606
2022
Q3 		– Sell
-281
Closed -$7K – 1938
2022
Q2 		$7K Sell
281
-1,170
-81% -$29.4K ﹤0.01% 1692
2022
Q1 		$37K Sell
1,451
-464
-24% -$12.3K 0.02% 1220
2021
Q4 		$59K Buy
1,915
+672
+54% +$18.9K 0.03% 1014
2021
Q3 		$30K Buy
1,243
+781
+169% +$14.3K 0.02% 881
2021
Q2 		$7K Buy
+462
New +$9.11K ﹤0.01% 1051

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wyoming's TVTX Position: Q1 2026 in Review

State of Wyoming sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 961 shares — an estimated $36.7K sold.

State of Wyoming first reported a position in TVTX in Q2 2021 and held it in 6 quarters. The position peaked at $59K in Q4 2021. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • State of Wyoming reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 961 Travere Therapeutics shares in Q1 2026, an estimated $36.7K.
  • State of Wyoming first reported a position in Travere Therapeutics in Q2 2021 and held it in 6 quarters.
  • State of Wyoming's Travere Therapeutics position peaked at $59K in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.